Fear of change is a key limiting factor that is slowing the adoption and value of AI across life sciences. It doesn't have to ...

Proper legal structuring is essential when it comes to transferring Chinese biotech intellectual property and clinical assets ...

Sometimes the key to making a breakthrough in research, in any field, is to look at the problem differently than anybody has ...

Cuts to federal research funding at universities and research organizations are pushing academic scientists into life ...

BIO was as busy as ever in Boston this year. With more to come soon, here are a few initial thoughts on three events I ...

New IRS requirements for R&D tax credits are coming into effect for tax year 2025. Life sciences companies should prepare for ...

Koshy George is a true Medicine Man. He knew as a young boy growing up in India that he wanted to make medicine. With his parents encouragement, he earned both a Bachelor and Master degree in Pharmacy ...

Experts at PA Consulting offer case studies and advice for using generative AI to improve biopharma manufacturing, mitigate ...

By Rob Wright, Chief Editor, Life Science Leader Follow Me On Twitter @RfwrightLSL. Chris Anzalone. It was the summer of 2007 when Chris Anzalone, Ph.D., got a call from Arrowhead Research Company. At ...

When Tryon Medical Partners left a large medical system in 2018 to once again become an independent group, clinical research was part of our stated mission. Our group of over 100 physicians now has ...

For people living with schizophrenia, the current drug treatment landscape is filled with cracks, crevices, and canyons that prevent a majority of patients from reaching anything close to a normal ...

As pharmaceutical manufacturers grow, they often pursue external sources of innovation to supplement their own R&D efforts. A recent study found that 45% of drugs in the pipelines of 20 large ...